1. 1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies. (31st December 2020) Authors: Teichner, Paula; Wu, Sterling; Zhang, Feifan; Dorey, David; D'Amico, Ronald; Griffith, Sandy; Sutton, Kenneth; McCoig, Cynthia C; Upadhyay, Ojesh R; Polli, Joseph; Margolis, David; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; Spreen, William; Patel, Parul Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 638. Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results. (31st December 2020) Authors: Smith, Graham; Henry, Keith; Podzamczer, Daniel; Masiá, Mar; Bettacchi, Christopher; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Sutton, Kenneth; Zhang, Feifan; McCoig, Cynthia C; Vandermeulen, Kati; Van Solingen-Ristea, Rodica; Spreen, William; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. Issue 10267 (19th December 2020) Authors: Overton, Edgar T; Richmond, Gary; Rizzardini, Giuliano; Jaeger, Hans; Orrell, Catherine; Nagimova, Firaya; Bredeek, Fritz; García Deltoro, Miguel; Swindells, Susan; Andrade-Villanueva, Jaime Federico; Wong, Alexander; Khuong-Josses, Marie-Aude; Van Solingen-Ristea, Rodica; van Eygen, Veerle; Crau... Journal: Lancet Issue: Volume 396:Issue 10267(2020) Page Start: 1994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials. (1st December 2020) Authors: Rizzardini, Giuliano; Overton, Edgar T.; Orkin, Chloe; Swindells, Susan; Arasteh, Keikawus; Górgolas Hernández-Mora, Miguel; Pokrovsky, Vadim; Girard, Pierre-Marie; Oka, Shinichi; Andrade-Villanueva, Jaime F.; Richmond, Gary J.; Baumgarten, Axel; Masiá, Mar; Latiff, Gulam; Griffith, Sandy; Harrin... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 85:Number 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗